Preventix

Philippines
Torres, Pangasinan, Philippines

Company profile

Preventix company profile

Preventix is a unique, minimally invasive screening test developed by the Mexican research laboratory Timser for the early detection of cervical cancer. Unlike traditional methods such as the Pap smear, which require collecting cervical cells using a speculum, Preventix detects specific biomarkers in the blood that indicate inflammation or lesions in the cervix. The test analyzes a 53-element blood chemistry panel to determine the presence of inflammation or precancerous changes.

Business identity

Contact email
[email protected]
Phone number
56 32 30 71 57
Operating status
Active
Employee range
1-10 employees
Founded
2019-01-01, Year

Headquarters

Country code
PH
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$3.5M
Last funding
Seed / $3.5M / 2025-05-22
Last equity funding
Seed / $3.5M
Investors
1
Lead investors
1
Articles
2

Founders and investors

Lead investors

Impacta VC

Investors

Impacta VC